Journal Title：Assay And Drug Development Technologies

ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.

ASSAY and Drug Development Technologies coverage includes:

-Assay design, target development, and high-throughput technologies-

Hit to Lead optimization and medicinal chemistry through preclinical candidate selection-

Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis-

Approaches to assays configured for gene families, inherited, and infectious diseases-

Assays and strategies for adapting model organisms to drug discovery-

The use of stem cells as models of disease-

Translation of phenotypic outputs to target identification-

Exploration and mechanistic studies of the technical basis for assay and screening artifacts

《分析和藥物開發(fā)技術》提供了新技術和強大工具，可實現(xiàn)早期篩選的關鍵進展。本期刊上發(fā)表的這項研究為藥物發(fā)現(xiàn)和開發(fā)提供了重要的治療方法和平臺。這本享有盛譽的同行評審期刊刊登原創(chuàng)論文、應用型技術評論、新興研究領域的專題以及方法和技術應用報告。

分析和藥物開發(fā)技術報道包括：

-分析設計、靶標開發(fā)和高通量技術-

通過臨床前候選藥物選擇實現(xiàn)先導化合物優(yōu)化和藥物化學-

實驗室自動化、樣品管理、生物信息學、數(shù)據(jù)挖掘、虛擬篩選和數(shù)據(jù)分析-

針對基因家族、遺傳和傳染病配置的分析方法-

使模型生物適應藥物發(fā)現(xiàn)的分析和策略-

使用干細胞作為疾病模型-

將表型輸出轉化為靶標識別-

分析和篩選制品的技術基礎探索和機制研究

Assay And Drug Development Technologies創(chuàng)刊于2002年，由Mary Ann Liebert Inc.出版商出版，收稿方向涵蓋生化研究方法 - 醫(yī)學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業(yè)影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 12周，或約稿 ，影響因子指數(shù)1.6，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。